Leptin-Induced Endothelial Dysfunction: A Target for Therapeutic Interventions

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|4|603-608

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.4, 2014-02, pp. : 603-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Leptin and the Cardiovascular System - A Target for Therapeutic Interventions

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 601-602

Bentham Science Publishers

Access to resources Recommend Favorite

CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3721-3730

Bentham Science Publishers

Access to resources Recommend Favorite

Autophagy Inhibition Rescues Against Leptin-Induced Cardiac Contractile Dysfunction

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 675-683

Bentham Science Publishers

Access to resources Recommend Favorite

ABAD: A Potential Therapeutic Target for A&bgr;-Induced Mitochondrial Dysfunction in Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-07 ,pp. : 1002-1008

Bentham Science Publishers

Access to resources Recommend Favorite

Shp2 as a therapeutic target for leptin resistance and obesity

By Feng Gen-Sheng  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 135-142

Informa Healthcare

Access to resources Recommend Favorite